Are Migraine Patients at Increased Risk for Symptomatic Coronavirus Disease 2019 Due to Shared Comorbidities? – Wiley

Introduction
While severe acute respiratory syndrome coronavirus 2 (SARSCoV2) keeps on rapidly spreading around the world and affects more than 32 million people up to now, reports about the neurological manifestations associated with SARSCoV2, as a potential predictor of poor outcome are still scarce. It is reported that a variety of symptoms and syndromes such as headache, dizziness, confusion, ataxia, epilepsy, ischemic stroke, neuropathic pain, and myopathy are common especially in more severe…

Click here to view the original article.